The aforementioned favorable in vivo properties (being in contrast to the somewhat discouraging in vitro results) can be attributed to the concomitant expression of both target structures on the tumor cell surface under in vivo conditions where the growing tumor obviously additionally expressed αvβ3 instead of GRPR alone. The gene discussed is GRPR; the disease is neoplasm.